Protalix BioTherapeutics (PLX) Treasury Shares (2012 - 2025)
Protalix BioTherapeutics' quarterly Treasury Shares came in at $739594.0 in Q4 2025, down 14.28% year-on-year from $862816.0 in Q4 2024, and down 14.28% quarter-over-quarter from $862816.0 in Q4 2024.
Protalix BioTherapeutics has reported Treasury Shares for 10 years, with the latest figure at $739594.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares fell 14.28% year-over-year to $739594.0; the trailing twelve-month figure through Dec 2025 stood at $739594.0 (down 14.28% YoY), and the FY2025 full-year result was $739594.0, down 14.28% from the prior year.
- Treasury Shares for Q4 2025 stood at $739594.0, down from $862816.0 in the prior quarter.
- The five-year high for Treasury Shares was $1.2 million in Q4 2023, with the low at $291474.0 in Q4 2022.
- Average Treasury Shares over 5 years is $705116.2, with a median of $739594.0 recorded in 2025.
- Year-over-year, Treasury Shares slumped 36.36% in 2022 and jumped 302.67% in 2023.
- Tracing PLX's Treasury Shares over 5 years: stood at $458027.0 in 2021, then tumbled by 36.36% to $291474.0 in 2022, then jumped by 302.67% to $1.2 million in 2023, then retreated by 26.49% to $862816.0 in 2024, then fell by 14.28% to $739594.0 in 2025.
- The last three Treasury Shares figures came in at $739594.0 (Q4 2025), $862816.0 (Q4 2024), and $1.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 739,594.00 |
| Dec 31, 2025 | 739,594.00 |
| Dec 31, 2024 | 862,816.00 |
| Dec 31, 2024 | 862,816.00 |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 291,474.00 |
| Dec 31, 2022 | 291,474.00 |
| Dec 31, 2021 | 458,027.00 |
| Dec 31, 2021 | 458,027.00 |
| Dec 31, 2020 | 624,580.00 |
| Dec 31, 2020 | 624,580.00 |
| Dec 31, 2015 | 127,874.00 |
| Dec 31, 2015 | 127,874.00 |
| Dec 31, 2014 | 386,124.00 |
| Dec 31, 2014 | 386,124.00 |
| Dec 31, 2013 | 970,208.00 |
| Dec 31, 2013 | 970,208.00 |
| Dec 31, 2012 | 1.39 Mn |
| Dec 31, 2012 | 1.39 Mn |